Research output per year
Research output per year
Personal profile
Biography
Harry Heijerman earned his MD (1984, cum laude) and his PhD in 1991 ("Studies in the clinical management of Cystic Fibrosis") He registered as pulmonologist in 1989, all above at the Leiden University Medical School. From 1996 till 2017 he was head of the department of Pulmonology at the Haga teaching Hospital in The Hague. Since 2017 he is head of the Department of Pulmonology and professor at the University Medical Center Utrecht The Netherlands. During his whole career he focussed on optimization of treatment for people with Cystic Fibrosis. He was PI of multiple mono and multi center studies focusing on understanding and treating Cystic Fibrosis. In 2002 he was the founding editor of the "Journal of Cystic Fibrosis". At present he is involved in several clinical studies addressing CFTR function in Cystic Fibrosis with the aim to find a cure for this life long inheritable disease, This work is done in close collaboration with the department of Pediatric Pulmonology.
Side activities
Chairman of the medical advisory board of the Dutch CF Foundation (NCFS)
Advisory board member Vertex Pharmaceuticals (2019)(Payments to UMC Utrecht)
Speaker fees:
Gilead 2020 (payments to UMC Utrecht)
Vertex 2019 (payments to UMC Utrecht)
External positions
Voorzitter adviesraad zorg - Expertise op het gebied van Cystic Fibrosis in mijn functie van longarts - Nederlandse Cystic Fibrosis stichting
1 Apr 2017 → 31 Dec 3999
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy
Burgel, P.-R., Ballmann, M., Drevinek, P., Heijerman, H., Jung, A., Mainz, J. G., Peckham, D., Plant, B. J., Schwarz, C., Taccetti, G. & Smyth, A., 3 May 2024, In: BMJ open respiratory research. 11, 1, p. 1-9 9 p., e002049.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study
van der Meer, R., Wilms, E. B., Eggermont, M. N., Paalvast, H. M., van Luin, M., van Rossen, R. C. J. M. & Heijerman, H. G. M., May 2024, In: Journal of Cystic Fibrosis. 23, 3, p. 549-553 5 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
Semenchuk, J., Naito, Y., Charman, S. C., Carr, S. B., Cheng, S. Y., Marshall, B. C., Faro, A., Elbert, A., Gutierrez, H. H., Goss, C. H., Karadag, B., Burgel, P. R., Colombo, C., Salvatore, M., Padoan, R., Daneau, G., Harutyunyan, S., Kashirskaya, N., Kirwan, L. & Middleton, P. G. & 14 others, , Sept 2024, In: Journal of Cystic Fibrosis. 23, 5, p. 815-822 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial
25 Apr 2024, In: BMJ Open. 14, 4, e076338.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Development and outcomes of a patient driven cystic fibrosis quality of care improvement project
Noordhoek, J. J., Jeyaratnam, J., Zomer, D., Gulmans, V. A. M., van der Ent, C. K. & Heijerman, H. G. M., Jan 2023, In: Journal of Cystic Fibrosis. 22, 1, p. 172-178 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Prizes
-
Officier in de orde van Oranje Nassau
Heijerman, Harry (Recipient), 27 Sept 2017
Prize: Honorary degree